Table of contents

October 2008 Vol 8 No 10

Also this month:


From the editors

p733 | doi:10.1038/nrc2520

Top

Research Highlights

Therapy: Developmental parallels | PDF (171 KB)

p735 | doi:10.1038/nrc2517

Tumorigenesis: Understanding one's origins | PDF (150 KB)

p736 | doi:10.1038/nrc2506

Therapy: Combine and conquer | PDF (140 KB)

p736 | doi:10.1038/nrc2519

RNA biology: There's nothing abnormal about chimeric RNA | PDF (140 KB)

p737 | doi:10.1038/nrc2511

Tumorigenesis: Taking the MYC | PDF (168 KB)

p738 | doi:10.1038/nrc2508

Evolution: Deep down | PDF (152 KB)

p738 | doi:10.1038/nrc2509

In the news

All clear for now | PDF (99 KB)

p738 | doi:10.1038/nrc2518

In brief

Metastasis | Oncogenes | Signalling | PDF (126 KB)

p739 | doi:10.1038/nrc2515

Cell division: Back and forth | PDF (155 KB)

p740 | doi:10.1038/nrc2514

Trial Watch

Skin Deep | Global risk and incidence | PDF (131 KB)

p740 | doi:10.1038/nrc2516

Epigenetics: Rewriting the ending | PDF (134 KB)

p741 | doi:10.1038/nrc2512

Metastasis: Micro silencing | PDF (106 KB)

p741 | doi:10.1038/nrc2513

Genetics: More than one way.... | PDF (151 KB)

p742 | doi:10.1038/nrc2510

Top

Reviews

Basal cell carcinomas: attack of the hedgehog

Ervin H. Epstein

p743 | doi:10.1038/nrc2503

The discovery that aberrant Hedgehog signalling can lead to the development of basal cell carcinoma (BCC) has facilitated a remarkable increase in our understanding of BCC. How is this information being used to refine the treatment of this disease?

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Jane E. Visvader & Geoffrey J. Lindeman

p755 | doi:10.1038/nrc2499

In this Review article, the authors discuss the evidence supporting the existence of CSCs in solid tumours.

See also: | Correspondence by Olivier Gires et.al | Correspondence by Geoffrey J. Lindeman et.al |

Article series: RB and E2F

The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system

Kay F. Macleod

p769 | doi:10.1038/nrc2504

This Review assesses emerging data that indicate a specific role for the RB tumour suppressor pathway in the response of the haematopoietic system to oxidative stress, and discusses the relevance of these findings to future cancer therapies.

The TRAIL apoptotic pathway in cancer onset, progression and therapy

Ricky W. Johnstone, Ailsa J. Frew & Mark J. Smyth

p782 | doi:10.1038/nrc2465

Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors (TRAILR1 and TRAILR2) are promising targets for cancer therapy: both recombinant TRAIL and monoclonal antibodies that target these receptors have entered clinical trials. How are these agents faring? What are the current stumbling blocks?

Top

Perspectives

Opinion

Replication licensing and cancer — a fatal entanglement?

J. Julian Blow & Peter J. Gillespie

p799 | doi:10.1038/nrc2500

Replication licensing proteins are inappropriately expressed and misregulated in a wide variety of cancers. What are the consequences for DNA replication and genomic stability?

Opinion

Bone morphogenetic protein signalling in colorectal cancer

James C. Hardwick, Liudmila L. Kodach, G. Johan Offerhaus & Gijs R. van den Brink

p806 | doi:10.1038/nrc2467

Mutations in the bone morphogenetic protein pathway have been found in juvenile polyposis, an inherited polyposis syndrome that predisposes to colorectal cancer. What relevance do these findings have to sporadic cases of colorectal cancer?

Opinion

Can genes for mammographic density inform cancer aetiology?

Linda E. Kelemen, Thomas A. Sellers & Celine M. Vachon

p812 | doi:10.1038/nrc2466

High mammographic density (MD) is an established risk factor for breast cancer. In theory, the number of genes that regulate MD should be smaller than that influencing breast cancer risk. How informative have the initial studies of the genetics of MD proved to be?

Correspondence

Correspondence: Opinions regarding cord blood use need an update

J. J. Nietfeld

p823 | doi:10.1038/nrc2418-c1

Correspondence: Cord blood stem cells: worth the investment

David T. Harris

p823 | doi:10.1038/nrc2418-c2

Correspondence: Banking on cord blood stem cells

Michael J. Sullivan

p823 | doi:10.1038/nrc2418-c3

Correspondence: Towards a hybrid model for the cryopreservation of umbilical cord blood stem cells

Zafiris Polymenidis & George P. Patrinos

p823 | doi:10.1038/nrc2418-c4

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

naturejobs

natureproducts


Advertisement